Split History
ETFs Holding REPH »    REPH Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Recro Pharma is a contract development and manufacturing organization, with integrated solutions for the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. Co. develops and/or manufactures the following key products with its key commercial partners: Ritalin LA® for Attention Deficit Hyperactivity Disorder, Focalin XR® for Attention Deficit Hyperactivity Disorder, Verelan PM®, Verelan SR®, Verapamil PM for hypertension, Verapamil SR for hypertension and Zohydro ER® for severe pain, as well as supporting development stage products. According to our REPH split history records, Recro Pharma has had 1 split.
REPH split history picture
Recro Pharma (REPH) has 1 split in our REPH split history database. The split for REPH took place on November 22, 2019. This was a 1115 for 1000 split, meaning for each 1000 shares of REPH owned pre-split, the shareholder now owned 1115 shares. For example, a 1000 share position pre-split, became a 1115 share position following the split.

When a company such as Recro Pharma splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the REPH split history from start to finish, an original position size of 1000 shares would have turned into 1115 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Recro Pharma shares, starting with a $10,000 purchase of REPH, presented on a split-history-adjusted basis factoring in the complete REPH split history. REPH split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 03/07/2014
End date: 06/23/2021
Start price/share: $7.44
End price/share: $2.04
Starting shares: 1,344.09
Ending shares: 1,592.33
Dividends reinvested/share: $2.80
Total return: -67.52%
Average Annual Total Return: -14.28%
Starting investment: $10,000.00
Ending investment: $3,247.82
Years: 7.30
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2014
End date: 06/23/2021
Start price/share: $7.44
End price/share: $2.04
Dividends collected/share: $2.80
Total return: -34.95%
Average Annual Total Return: -5.72%
Starting investment: $10,000.00
Ending investment: $6,505.76
Years: 7.30
Date Ratio
11/22/20191115 for 1000
REPH is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

RGLS Split History
RHE Split History
RMD Split History
RNN Split History
RNVA Split History
ROCM Split History
ROKA Split History
ROSG Split History
RPTP Split History
RSLS Split History

Also explore: REPH shares outstanding history

Trisura Group Ltd. (TSU.CA)
BetaPro NASDAQ-100 2x Daily Bull ETF (HQU)
BetaPro S&P 500 2x Daily Bull ETF (HSU)
BetaPro S&P/TSX Capped Energy 2x Daily Bull ETF (HEU)
BetaPro S&P/TSX Capped Financials 2x Daily Bull ETF (HFU)
BetaPro S&P/TSX 60 2x Daily Bull ETF (HXU)
BetaPro Crude Oil Leveraged Daily Bull ETF (HOU)
Horizons Big Data & Hardware Index ETF (HBGD.U)
Horizons Big Data & Hardware Index ETF (HBGD)
Horizons NASDAQ-100 Index ETF (HXQ.U)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

REPH Insider Buying

REPH Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.